Opera Fans Experience Worse Than Expected Side Effects of Prostate Cancer Treatment


Largo, FL (PRWEB) May 07, 2014

In a survey of more than 200 men with prostate cancer and their caregivers, BioDerm found that opera fans were more than 40% more likely than non-opera fans to report that their side effects after prostate cancer treatment were worse or much worse than expected. By comparison, fans of classical music, country, pop and rap did not display any correlation with side effects. And blues music fans were only 20% more likely to report worse side effects.

Its way too soon to establish a definitive link, says statistician and VP of Technology, Steve Babb. But its definitely an interesting correlation. Im not sure Ill be putting on any Puccini anytime soon, just in case!

There are more than 2.5 million men in the US whove been diagnosed prostate cancer during their lifetimes. According to the American Cancer Society more than 200,000 men are diagnosed and nearly 30,000 men die of prostate cancer every year.

For survivors, the most common complications of prostate cancer treatment are erectile dysfunction and urinary incontinence. According to the same survey, 46% of prostate cancer survivors reported dealing with ongoing urinary incontinence. This number is much higher than you see in physician reported studies which typically list a 5-8% incontinence rate.

The root of this inconsistency is unknown, says Babb. Based on our clients experiences, we believe that it may be that physicians and patients define incontinence differently and that can vastly change the numbers. Well have to do a follow up evaluation to find out for sure.

Its was a very surprising connection to us. It definitely wasnt what we went in looking for, said BioDerm CEO, Gary Damkoehler. We started this because we talk to hundreds of prostate cancer survivors on a monthly basis and we wanted to know what connected them. For us, its all about knowing who our clients are and how we can best reach them. So we looked for any connection that can help our patients and healthcare professionals better understand life after prostate cancer.

BioDerm has been working with incontinence patients for nearly ten years, trying to help them find a better way to manage this serious condition. BioDerm is the manufacturer of Mens Liberty, a male external collection device designed especially for community dwelling men who want to be active throughout their golden years. You can find more info here: http://www.BioDermInc.com. For full survey results, please contact swoodward(at)bioderminc(dot)com.







More Erectile Dysfunction Press Releases

Macromark, One of the Top Direct Mail and Targeted List Brokers in the U.S., Announces Success of PRO+PLUS Supplements List


Danbury, CT (PRWEB) October 08, 2014

Macromark (http://www.Macromark.com), a progressive direct mail company specializing in acquisition, retention and monetization, is announcing the success of its PRO+PLUS supplements list, which has been part of its portfolio since 2010.

Its been a strong list for us for a good while now, says Dave Klein, CEO and president of Macromark Inc. Its suited to a specific consumer, which is a benefit when running any targeted direct mail campaign. The more specific the list, the more focused the campaign.

Men looking to purchase the PRO+PLUS supplement are interested in increasing their sex drive, as well as the length and frequency of their sexual engagements. Using a natural herbal formula, the supplement can result in increased erection size and more powerful orgasms. (Source: Product information, PRO+PLUS web site; http://www.proplusmedical.com/penis-enlargement.html, last accessed October 6, 2014.)

Its very much a libido-driven supplement, Klein adds. Men typically want to do what they can to improve their performance, and this product provides them with a safe and effective means to make that possible.

According to Klein, this male-targeted herbal virility enhancement product gets heavy full-page promotion across many popular mens magazines, health and fitness publications, and automotive and motorcycle magazines.

With a strong average order value of $ 120, this targeted direct mail list is a must-test for all herbal supplement, mens health, sports, music, cigars, and catalogue and insurance mailers, Klein concludes.

Macromark specializes in providing targeted and relevant consumer and business lists used for prospecting, lead generation, and direct marketing sales. The company is one of the largest direct mail and targeted list brokers in the U.S., providing additional services in e-commerce, insert media, print media buying, and database marketing services. Macromark currently has over 300 consumer and business-to-business clients across the U.S., Canada, and internationally. The company prides itself on exemplary service and clear list management and brokerage objectives. To learn more about Macromark, visit http://www.macromark.com, contact Macromark at 845-230-6313 or by e-mail at david@macromark.com, or visit its location at 39 Old Ridgebury Road, Suite C3, Danbury, Connecticut, 06810.







Window & Door Installation Services Procurement Category Market Research Report from IBISWorld Has Been Updated


Los Angeles, CA (PRWEB) October 10, 2014

Window and door installation services have a buyer power score of 2.9 out of 5. According to IBISWorld analyst Deonta Smith, the buyer score reflects a solid market for buyers in terms of their ability to negotiate favorable contractual terms; however, during the three years to 2014, buyer purchasing power declined mainly due to rising prices. Market service prices are heavily dependent on the trends and fluctuations in residential, commercial, industrial and other construction markets.

The value of residential and nonresidential construction increased during the three years to 2014, as the economy rebounded from the building slump during the recession. In addition, private spending on home improvements grew at a strong rate. These trends led to steady price growth for window and door installation services, negatively affecting buyers, continues Smith. In the three years to 2017, prices are forecast to continue their growth trajectory as the economy stabilizes and construction activity continues to rise. This will further restrain buyers’ ability to negotiate favorable prices.

Moreover, the rising prices of wood paneling and windows, which are the main inputs for market suppliers, have also driven market prices up, leaving buyers with less room for price negotiation. In addition, the market’s high switching costs further limit buyer power, giving suppliers more leverage to establish prices. Likewise, the lack of substitutes has given suppliers greater flexibility in determining prices, further hurting buyers.

Nevertheless, high market fragmentation and mounting competition benefit buyers by creating a larger pool of suppliers to choose from. Some major market suppliers include Sears Holding Corporation, Pella Corporation and Milgard Manufacturing Inc. Suppliers are increasingly engaging in price-based competition to win new customers and maintain or gain market share in a highly saturated market. In recent years, this has allowed buyers to bid multiple suppliers against each other, and create more favorable price terms. While market fragmentation has benefited buyers, its impact has been mitigated by rising services prices brought on by a postrecession surge in construction activity. For more information, visit IBISWorlds Window & Door Installation Services procurement category market research report page.

Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld

Like IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189

IBISWorld Procurement Report Key Topics

This report is intended to assist buyers of window and door installation and erection services. Suppliers provide garage door and prefabricated window and door installation, entryway and exit framing, metal stud installation and store fixture installation services.

Executive Summary

Pricing Environment

Price Fundamentals

Benchmark Price

Pricing Model

Price Drivers

Recent Price Trend

Price Forecast

Product Characteristics

Product Life Cycle

Total Cost of Ownership

Product Specialization

Substitute Goods

Regulation

Quality Control

Supply Chain & Vendors

Supply Chain Dynamics

Supply Chain Risk

Imports

Competitive Environment

Market Share Concentration

Market Profitability

Switching Costs

Purchasing Process

Buying Basics

Buying Lead Time

Selection Process

Key RFP Elements

Negotiation Questions

Buyer Power Factors

Key Statistics

About IBISWorld Inc.

IBISWorld is one of the world’s leading publishers of business intelligence, specializing in Industry research and Procurement research. Since 1971, IBISWorld has provided thoroughly researched, accurate and current business information. With an extensive online portfolio, valued for its depth and scope, IBISWorlds procurement research reports equip clients with the insight necessary to make better purchasing decisions, faster. Headquartered in Los Angeles, IBISWorld Procurement serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.







Businessweek: Prices Doubling for Dozens of Established Drugs; polyDNA Reviews the Article and Recommends Affordable, Effective, Natural Remedies


Rochester, NY (PRWEB) May 17, 2014

Since October 2007 the cost of brand-name medicines has soared, with prices doubling for dozens of established drugs that target everything from multiple sclerosis to cancer, blood pressure, and even erectile dysfunction, according to an analysis conducted for Bloomberg (1). These high costs also affect antiviral drugs normally used to treat herpes simplex virus (HSV) infections. During the past three years, prices of antiviral drugs have increased at an estimated average annual rate of 7.4%. Although they have low volatility, the increasing prices of antiviral drugs have been unfavorable for buyers, primarily thanks to patent activity. (See the IBISWorlds Antiviral Drugs Procurement Research Report, published October 2013) (2). polyDNA recommends that individuals with a herpes infection talk to their doctors about the affordable natural HSV remedies, Gene-Eden-VIR and Novirin. The formula of these natural antiviral products was shown to reduce herpes symptoms in two separate post-marketing clinical studies that followed FDA guidelines.

While the costs of drugs for most major diseases are increasing, doctors are learning to become advocates for their patients wallets. Doctors are for the first time exploring ways to better educate patients on the gains and costs that can be expected from the drugs they prescribe. A leading organization of cancer doctors, the American Society of Clinical Oncology, is working on an algorithm for rating the cost-effectiveness of expensive oncology drugs and will urge physicians to use the system to discuss the costs with their patients (1).

polyDNA agrees with this trend and hopes it continues. In order to encourage this trend, polyDNA recommends Gene-Eden-VIR and Novirin as the most affordable means of treating a latent herpes infection.

To help customers who suffer from herpes infections, polyDNA compared the cost of Valtrex, Acyclovir (Zovirax), and Gene-Eden-VIR. The first two are FDA approved medications while the third is a natural, antiviral remedy. The first two target the active herpes virus, while the third was designed to target the latent virus. According to goodrx.com, the cost of a months supply of Valtrex (90 pills), one of the most common anti-herpes medications, is $ 1401.00 for the brand name at the CVS Pharmacy. (1) The cost of the generic brand is only slightly less. While Zovirax (Acyclovir) is significantly cheaper, this herpes medication still costs at least $ 148.41 for oral suspension. (See GoodRx.com) (3).

The Gene-Eden-VIR/Novirin formula is the only natural antiviral product that was tested according to FDA guidelines for safety and efficacy. A months supply of Gene-Eden-VIR is $ 42.99 and the cost of Novirin is $ 52.99. Thats much cheaper than Zovirax, and well over $ 1,000 cheaper than Valtrex.

Novirin shares the same formula as Gene-Eden-VIR. The difference between the two is that Novirin has higher quality, more expensive ingredients. The Novirin/Gene-Eden-VIR formula was tested in two post-marketing clinical studies published in September 2013 and March 2014, respectively, in the peer reviewed medical journal Pharmacy & Pharmacology (4).

Interested individuals can view the two published studies here, http://cbcd.net/Gene-Eden-VIR-Clinical-Study.php and http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.

Up to 70% of those studied reported a decrease in symptoms associated with CMV infection, and users of the Novirin/Gene-Eden-VIR formula experienced an increase in overall health (4).

Each ingredient of Gene-Eden-VIR and Novirin was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the highest quality, safest, most effective natural ingredients that target latent viruses.

A second clinical study showed that the Novirin/Gene-Eden-VIR formula decreased physical and mental fatigue. (See Pharmacology & Pharmacy, from March, 2014) (5).

As the price of drugs continues to hit the public where it hurts, we believe individuals should begin looking at affordable remedies that are proven to work. We recommend that individuals infected with herpes talk to their doctors about Gene-Eden-VIR and Novirin. These natural antivirals were designed to help the immune system target the latent herpes virus. – Mike Evans, polYDNA

To learn more about Novirin, visit http://www.novirin.com and about Gene-Eden-VIR, visit http://www.gene-eden-vir.com.

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

Global Baking Powder Market is Expected to Reach USD 3.36 Billion by 2019: Transparency Market Research


Albany, NY (PRWEB) May 19, 2014

Transparency Market Research launched a new market report titled “Baking Powder Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 – 2019″. The global baking powder market witnessed growth in recent years due to growing fast food industry. Substitution by baking soda and adverse effects of baking powder are the major growth barriers to the market growth. However, new product launches are stimulating market growth.

Browse Global Baking Powder Market Report with Full TOC: http://www.transparencymarketresearch.com/baking-powder-market.html

Nowadays, due to increasing health concerns, people avoid usage of aluminum based baking powder since aluminum intake has been implicated in several health issues such as Alzheimer’s. Thus, the aluminum free baking powder market is expected to grow at a CAGR of 6.1% in terms of revenue from 2013 to 2019.

Asia Pacific dominated the global baking powder market and accounted for over 36.3% of the global demand in 2012 in terms of revenue, followed by Europe, which accounted for 28.5% share for the same year in terms of revenue. Moreover, in the future, Asia Pacific will remain the most promising market with an estimated CAGR of 5.6% in terms of revenue from 2013 to 2019. Economies such as China, India and Japan are expected to be the chief contributors to this growth. Nuclear families and an increase in the number of working women are some of the cultural traits that have influenced people’s lifestyle and thus there is a shift towards ready to eat foods in these regions.

Related & Recently Published Reports by Transparency Market Research

Electronic Recycling Market: http://www.transparencymarketresearch.com/electronics-recycling-market.html
Erectile Dysfunction Drugs Market: http://www.transparencymarketresearch.com/erectile-dysfunction-drugs.html

There are many brands available in the market, such as Clabber girl and Rumford, Davis and Calumet; however, none have significant market share. Some of the major players of the market are ACH Food Companies Inc., Clabber Girl Corporation, Caravan Ingredients, Inc. and Weikfield Products Private Limited.

Baking Powder Market: Product Analysis

Phosphate
Anhydrous Phosphate
Sodium Aluminum Sulfate Phosphate
Tartrate
Aluminum-free
Phosphate-free
Others

Baking Powder Market: Regional Analysis

North America
Europe
Asia Pacific
RoW

Browse Global Baking Powder Market Report with Full TOC: http://www.transparencymarketresearch.com/baking-powder-market.html







Global Human Reproductive Technologies Market: Analysis, Size, Procedures, Growth, Trends and Forecast 2013 – 2019


Albany, New York (PRWEB) May 21, 2014

Human Reproductive Technologies Market was valued at USD 23.0 billion in 2012 and is expected to reach USD 27.1 billion in 2019, growing at a CAGR of 2.2% from 2013 to 2019.

Human reproductive technologies include procedures and therapies for conceiving or controlling pregnancy by means of artificial and/or semi artificial medical solutions. Lack of awareness about the reproductive deficiencies and their treatment necessity and availability has been limiting the market to explore its potential value. Therefore, awareness strategies adopted by market players with proper guidance for patients will fuel the emerging human reproductive technologies market especially the infertility treatment market. Developing regions such as the Asia-Pacific, Latin America, Africa and Middle-East hold the maximum growth potential in the human reproductive technologies market. Some of the other factors contributing to the growth of human reproductive technologies market include delay in conceiving, lifestyle habits such as smoking, excessive alcohol consumption, increasing use of contraceptive pills and devices, and rising incidences of infertility.

Browse Global Human Reproductive Technologies Market Report with Full TOC: http://www.transparencymarketresearch.com/human-reproductive-technologies-market.html

The infertility treatment market is characterized by the presence of many leading patented drug brands which are restraining the entry of generics and hence, creating a monopolistic situation. In addition, due to patient sentiments attached to infertility treatment procedures, risk ofno conception due to a low-quality generic drugis usually avoided. This report includes market analysis for seven major (by sales) branded formulations of infertility drugs, namely, Gonal-f, Follistim AQ, AndroGel, Testim, Viagra, Cialis and Levitra/Staxyn. Similarly, the contraceptive drugs and devices market has many drugs in the research pipeline awaiting commercialization to grab a share of this potential market. Large and well established pharmaceutical players such as Merck Serono, Merck & Co., Inc., Bayer AG, Pfizer, Inc., Actavis plc, Ferring International Center S.A. and Teva Pharmaceutical Industries Ltd. dominate the human reproductive technologies market.

The global contraceptives market was valued at USD 16.0billion in 2012 and is expected to grow at a CAGR of 5.5% from 2013 to 2019. The oral contraceptive pills market lead the overall contraceptives market in 2012 in terms of revenue, mainly due to increasing population awareness through advertisements enabling patients to buy them over-the-counter. In the contraceptive devices market, male condoms formed the largest market segment owing to the increased accessibility and awareness along with their ease of use.

The infertility drugs market studied in this report include leading brands from three drug classes, namely, gonadotropins, androgens and erectile dysfunction drugs. Among these, Viagra was the largest brand by revenue in 2012 among others considered in the study due to increasing cases of erectile dysfunction in male infertility. Moreover, it has been a well-established and popular brand since its approval in 1998 by the U.S. FDA. Gonal-f in the gonadotropin class is the leading brand prescribed by majority of the infertility specialist due to better results achieved using it. For testosterone deficiency which is one of the major infertility causes in male patients, AndroGel is the blockbuster drug being preferred for the treatment. Generic manufacturers such as Watson Pharmaceuticals and Par Pharmaceuticals are expected to enter the market with their generic versions by 2015.

Among the infertility procedures, intrauterine insemination (IUI) is the most preferred treatment procedure due to its low operational cost and equal success rate compared to intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF), which follow IUI in terms of preference. The simplicity of performing IUI is what attracts the healthcare professionals to prefer this procedure over others. Zygote intrafallopian transfer (ZIFT) and gamete intrafallopian transfer (GIFT) are the least popular procedures performed worldwide, accounting for about 0.1% of the total ART treatments. This is due to the higher procedural costs and complexity in performing these procedures.

Related & Recently Published Reports by Transparency Market Research

Microserver Market: http://www.transparencymarketresearch.com/microserver-market.html
Infusion Pumps Market: http://www.transparencymarketresearch.com/infusion-systems-market.html

North America dominated the global human reproductive technologies market in 2012 and is expected to maintain its leading market position till 2019. However, the Asia-Pacific contraceptive technologies market is estimated to grow at a faster pace (CAGR of 6.9% from 2013 to 2019) mainly to the rising awareness and acceptance of reproductive technologies in this region. Entry of large market players such as Merck Serono, Ferring International Center S.A. and Merck & Co., Inc.will also drive the market in the Asia-Pacific region.

Some of the key players in the global human reproductive technologies market include Abbott Laboratories, Bayer AG, Merck & Co., Inc., Merck Serono, Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Watson Pharmaceuticals and Reckitt Benckiser.

Browse Global Human Reproductive Technologies Market Report with Full TOC: http://www.transparencymarketresearch.com/human-reproductive-technologies-market.html

The global human reproductive technologies market is categorized into the following segments:

Human Reproductive Technologies Market, by Infertility Drugs

Gonal-f (recombinant follitropin alfa)
Follistim AQ (follitropin beta)
AndroGel (testosterone)
Testim (testosterone)
Viagra (sildenafil citrate)
Cialis (tadalafil)
Levitra/Staxyn (vardenafil)

Human Reproductive Technologies Market, by Infertility Procedures

In Vitro Fertilization (IVF)
Intracytoplasmic Sperm Injection (ICSI)
Zygote Intrafallopian Transfer (ZIFT)
Gamete Intrafallopian Transfer (GIFT)
Intrauterine Insemination (IUI)

Human Reproductive Technologies Market, by Contraceptive Technologies

Drugs

Oral Contraceptive Pills
Contraceptive Injectables
Topical Contraceptives

Devices

Male Contraceptive Devices (Male Condoms)
Female Contraceptive Devices
Female Condoms
Diaphragms
Sponges
IUDs
Hormonal IUDs
Copper IUDs
Subdermal Contraceptive Implants
Vaginal Rings

Human Reproductive Technologies Market,by Geography

North America
Europe
Asia-Pacific
Rest of the World (RoW)

Browse Global Human Reproductive Technologies Market Report with Full TOC: http://www.transparencymarketresearch.com/human-reproductive-technologies-market.html







More Erectile Dysfunction Press Releases

Deadly spider whose bite causes FOUR HOUR erection then KILLS found in

Deadly spider whose bite causes FOUR HOUR erection then KILLS found in
The species is deadly and its venom can kill a human in just two hours – but can also give male victims a painful four-hour erection. Its venom is currently being studied for use in erectile dysfunction treatments. Mother-of-two Maria went to open the …
Read more on Express.co.uk

Jones Bros joins BayWa payroll
Civil engineer Jones Bros has kicked off construction of BayWa's nine-turbine Fraisthorpe wind farm in North Yorkshire. The 29.7MW project near Bridlington features nine of the UK's first Vestas V112 3.3MW machines with a tip height of 125 metres.
Read more on reNews

FDA Notifies Not to Use MV5 Days: AttorneyOne Monitor and Keep Consumers Informed


San Diego, CA (PRWEB) May 22, 2014

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for MV5 Days.

The FDA notified consumers on May 16, not to purchase or use MV5 Days because it contains sildenafil. MV5 Days is promoted as a product for sexual enhancement.

Sildenafil is the active ingredient in Viagra, the FDA approved prescription drug used to treat erectile dysfunction. This ingredient may interact with nitrates found in certain drugs used to treat heart disease, high blood pressure and diabetes and can lower blood pressure to dangerous levels.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds we are determined to keep an eye on FDA announcements concerning MV5 Days and inform the public. For that reason”, he continues, “our focus should squarely fall on investigating these safety alerts and getting the word out.

As the FDA advises Do not purchase or use MV5 Days.

AttorneyOne.com has further information on MV5 Days at the website including latest major drug and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/05/prweb11871885.htm







Find More Erectile Dysfunction Press Releases

Back to School and the Newest Chemical to Watch: Phthalates

With children across the country returning to school this week, many parents are just completed the infamous back-to-school shopping trip, wherein backpacks, notebooks, pencils, markers, and locker decorations were purchased. This year, some scientists and politicians are warning about the dangers of phthalates.

Phthalates are also known as “plasticizers.” This is a group of industrial chemicals, used in everything from raincoats, shower curtains, toys, and children’s backpacks. According to the Environmental Working Group, phthalates can disrupt the endocrine system, decrease a man’s sperm count, and possibly even cause cancer.

This week, the Center for Health, Environment and Justice released the “Back-to-School Guide for PVC-Free School Supplies.” The report tells parents how to avoid PVCs, calling them “poisonous.” A number of media sources have picked up the story and are cautioning parents against purchasing products containing these chemicals. However, not everyone is necessarily ready to call phthalates a health hazard just yet.

An op-ed piece appearing on Forbes.com this week blasts the allegations made by some politicians and environmental groups, noting that many of the studies only involved animals or test groups so small that it would be irresponsible to draw sweeping conclusions from them:

Most recently, in NeuroToxicology, the Mt. Sinai Hospital researcher linked phthalates and another controversial plasticizer, bisphenol A, to a variety of health problems including neuro-developmental delays, behavioral issues and reduced fertility. Her evidence? She examined urine samples from 10 Mennonite women —yes, 10 of 1.5 million Mennonites worldwide. From a science perspective, any conclusions she might make from such a dismally small sample is literally ridiculous—but the media had a field day, nonetheless.

The truth is that there simply is not enough information out there at this point to make a definite determination regarding the safety of phthalates. These chemicals not not highly regulated, and science is still emerging about any potential long-term effects.

 

Surface Miners Inhaling Toxic Dust At Risk for Black Lung

Many surface coal miners previously believed that only their colleagues working underground were at risk for contracting black lung disease. A new study conducted by the National Institute for Occupational Safety and Health (NIOSH) says otherwise.

Black lung disease is simply a common name used to describe any lung disease that can be contracted by inhaling coal dust. The name is derived from the appearance of a person’s lungs, which normally appear to be pink. There are two types of black lung disease, also known as coal workers’ pneumoconiosis: coal workers’ pneumoconiosis (CWP or the “simple” form); and progressive massive fibrosis (PMF or the “complicated” form).

Utilizing chest x-rays and breathing tests, researchers at NIOSH discovered severe cases of black lung disease in surface coal miners. While a prior study, completed in 2002, revealed less than a 2% incidence rate of black lung disease, this current study revealed that the rate is actually about five times higher.

Although it is still somewhat unclear as to what specific chemicals are the most harmful, researchers have speculated that silica dust, found primarily in the Appalachian region, is especially dangerous.

Because of these findings, researchers are now alleging that federal regulations governing coal miners may be insufficient to protect workers. Currently, miners who work on the surface are often exposed to clouds of dust around coal trucks, mines, and along mine roadways.

Inhaling coal dust also increases the risk of contracting emphysema, chronic bronchitis, or COPD. X-rays are able to detect many lung diseases early, so workers who are concerned should get tested so that early treatment options are available to them. If an x-ray does reveal a formal positive diagnosis of black lung disease, workers have a legal right to be transferred to a less dusty working environment without a reduction in pay.

If you have suffered a lung injury from working in a coal mine or by inhaling toxic substances, contact our firm for a complimentary consultation or fill out the form below.

For more information on the study and on black lung disease, please see the following sources:

North Carolina Governor Rejects Fracking Legislation

On Sunday, North Carolina Governor Bev Perdue vetoed a bill which would have allowed companies to drill for natural gas in North Carolina through the highly controversial fracking process. (For background information on fracking, please see our blog post from August 24, 2011.) Governor Purdue said in a public statement that she did not believe the legislation contained adequate environmental protection.

“I support energy policies that create jobs and lower costs for businesses and families,” Perdue said. “Our drinking water and the health and safety of North Carolina’s families are too important; we can’t put them in jeopardy by rushing to allow fracking without proper safeguards.”

While Governor Perdue’s veto was criticized by the leadership in both the State House and Senate, the move received praise from a number of state and national environmental groups, who have been cautioning against the risks associated with fracking for many months now.

While Republicans in North Carolina supported fracking for its potential to create many jobs within the state, Democrats and many environmental groups fear that the process will contaminate drinking water and is therefore not worth the risk. They argue that releasing toxic chemicals into potable water could create massive health risks for those consuming water from sources near fracking sites.

To read more about the bill in North Carolina, please see the article in the Charlotte Observer.

If you or a loved one has been injured by contaminated water or soil, please contact our firm for a complimentary consultation to learn more about your rights.

New Vaccination Designed to Help Smokers Quit and Prevent Non-Smokers from Starting

British scientists have developed a vaccination that is designed to remove all addictive properties of nicotine. Specifically, the pleasure your body associates with smoking would no longer be generated when you smoke a cigarette.

While human trials for the vaccine have yet to begin, tests on mice have proven to be successful. After a single dose, mice were found to be immune to nicotine addiction for their entire lifespan.

The vaccine contains a harmless virus, which is engineered to generate anti-nicotine antibodies upon administration. The virus works by selectively affecting cells in the liver.

Because the vaccine works by turning liver cells into antibody generators, it is expected to cost far less than prior vaccines, which required antibodies to be administered directly. Because older vaccines have required numerous administrations of these antibodies, they were believed to be less effective and more costly.

If human trials are successful, scientists believe that the vaccine could be administered to children, who have never tried a cigarette. This should prevent any recipients of the vaccine from ever deriving pleasure from smoking.

To read more about the vaccine, please visit Sky News.

Certain Toxic Chemicals Possibly Linked to Autism

The product of a conference hosted by the Children’s Environmental Health Center (CEHC) in 2010 has gained publicity in the past few days. Philip Landrigan, MD, MSc, Luca Lambertini, PhD, MPH, MSc, and Linda Birnbaum, Director of the National Institute of Environmental Health Sciences, recently published an editorial called “A Research Strategy to Discover the Environmental Causes of Autism and Neurodevelopmental Disabilities.” The editorial focuses on certain toxic chemicals that the editors suggest are linked to autism.

Autism Awareness Ribbon

According to the National Academy of Sciences, 3 percent of neurobehavioral disorders in children are caused by exposure to toxins in the environment. The disorders in this category include ADHD and autism spectrum disorder (ASD). An additional 25 percent of these disorders are believed to be caused by a mix of exposure to environmental factors and genetics, though the exact causes are still unknown. Researchers at Mount Sinai have estimated that between 400,000 and 600,000 of the 4 million children born each year in the U.S. are affected by these issues.

For these reasons, Dr. Landrigan, as well as four other editorials, have called for additional studies to be conducted to determine which chemicals might be causing conditions like autism. The CEHC listed ten chemicals it believes to be linked to causing autism and learning disabilities. They are:

1. Lead

2. Methylmercury

3. PCBs

4. Organophosphate pesticides

5. Organochlorine pesticides

6. Endocrine disruptors

7. Automotive exhaust

8. Polycyclic aromatic hydrocarbons

9. Brominated flame retardants

10. Perfluorinated compounds

If you or a family member have been injured by exposure to a toxic substance, contact our firm for a complementary consultation. We have over 25 years of experience and would be happy to explain your legal options, free of cost.

For more information on these chemicals and their potential link to autism, please click here.

The New Drug of Choice: Hand Sanitizer?

While you certainly can’t sue over the subject matter of this post, this new trend is so baffling that it nonetheless merits attention. According to a recent article in the L.A. Times, a new trend is emerging on college campuses throughout the country: drinking hand sanitizer.

In the past year, the California Poison Control System announced that it has received sixty reported cases of teenagers drinking hand sanitizer. In order to kill all of those germs on your hands, sanitizer contains 62% ethyl alcohol. Unfortunately, many teens have begun to utilize the substance to create a very potent alcoholic beverage, which sometimes includes salt to separate out the alcohol. Some students reported locating instructions for making this stiff cocktail on the Internet.

If you are concerned that your child might be interested in experimenting, there are ways to continue using hand sanitizer, while minimizing the availability of the product around your house. According to Cyrus Rangan of the Children’s Hospital Los Angeles, “All it takes is just a few swallows and you have a drunk teenager.” Health experts have advised purchasing foam hand sanitizers instead of the liquid versions, as the foam is more difficult to transform into a legal beverage.

To read more about this, please see the following sources:

California Study Finds Toxins in Nail Polish

Reports in a variety of scientific journals demonstrate that nail salon employees suffer from more frequent headaches, respiratory issues, and skin irritation than most Americans. Furthermore, those working in nail salons are frequently exposed to dangerous chemicals at higher levels than most.

With this in mind, it is disturbing that the Department of Toxic Substances Control is releasing a report, showing that toxic chemicals were found in a number of nail products, claiming to be toxic-free. ”Toxic-free” refers to products not using the “toxic trio:” formaldahyde, toluene, and dibutyl phthalate. Exposure to these three chemicals has been linked to both cancer and birth defects.

According to Thu Quach of the Cancer Prevention Institute of California, nail products are not closely regulated, and the toxic effects of nail products can be compounded if a nail salon is not properly ventilated. Therefore, some cities have begun to pay attention and implement stricter regulations. While Boston has approached the issue by requiring salons to obtain health permits, the city of San Francisco has used an incentive approach by recognizing salons that use toxic-free products.

If you or a loved one have been injured by a toxic product, contact us for a complementary consultation.

For more information on toxic nail products, please see the article appearing in today’s Los Angeles Times.

Cancer Cluster in Fridley, MN? Erin Brockovich is on the Scene.

Shortly after wrapping up an investigation in upstate New York, Erin Brockovich has traveled to Fridley, Minnesota, where she and her team are now attempting to decipher what might be causing elevated cancer levels in the area. Current estimates place the incidence of cancer in Fridley at around ten percent higher than other areas in the state.

While heightened occurrences of all types of cancer are cause for concern, epidemiologists are working to trace which types of cancers are appearing more than others. John Soler, an epidemiologist for the Minnesota Cancer Surveillance System, indicated that initial findings revealed higher concentrations of lung cancer, especially in women. Despite this, Soler noted that final numbers have yet to be crunched.

In the meantime, Bob Bowcock, Brockovich’s associate, is reaching out to Fridley residents on the facebook page, “Fridley Cancer Cluster.” The page was started by residents and was one of the reasons Fridley caught Brockovitch’s attention.

The page has nearly 1,900 members and is full of stories from locals whose lives have been affected by cancer.

For more on this issue, please visit any of the following sites:

More Reasons to Quit Smoking

Just when you thought you had heard every possible reason under the sun to quit smoking, another one emerges. The latest incentive for kicking your habit comes from an article released today by Reuters. The article pronounces, not only is smoking bad for you, for your friends and family, for those around you, but it’s a “drag on the world economy.”

The Tobacco Atlas, funded by the American Cancer Society and World Lung Foundation, launched a book, which contains a number of statistics concerning the harm caused by tobacco. One of the most important figures indicates that smoking costs around 1 to 2 percent of the world’s gross domestic product every year. Included in these figures are costs such as healthcare expenses for treating tobacco-related illnesses and the costs of tobacco-related absences from work.

Today, there are around 7 billion people on the planet, and approximately one out of every seven smokes. Each year, approximately 600,000 non-smokers die as a result of second-hand smoke.

Sadly, these staggering statistics don’t seem so staggering after being in the news for so many years. The World Health Organization is taking action to curtail global tobacco use, and so are nations around the globe. As of today, 174 countries have signed and ratified the WHO’s Framework Convention on Tobacco Control.

While this is certainly a step in the right direction, the Convention lacks any penalties for a State’s failure to comply with Convention provisions. The United States has signed the treaty, but it has not been ratified. Therefore, the signature is nothing more than a symbolic gesture; treaties are not binding until they have been ratified.

While frightening statistics about tobacco use and related injuries have become the norm, and while one more article likely won’t cause anyone to to toss their last pack of Marlboros in the trash, it remains important to be reminded every once in a while that kicking the habit can not only save lives, but apparently, it can help our ailing economy.

Is Fluoride in Water Dangerous?

Recently, the New Jersey State Legislature introduced a bill, requiring all public water systems to add fluoride to local water supplies. This bill was proposed in light of the discovery that around two hundred New Jersey municipalities have stopped adding fluoride to water.

 

Fluoride prevents tooth decay and guards against the development of cavities. According to WebMD, the mineral allows teeth to resist being damaged by bacteria and sugars in the mouth, and it reversed early tooth decay. In fact, the Center for Disease Control and Prevention has hailed the addition of fluoride to local water supplies as one of the top ten public health achievements of the 20th century.

Objections to fluoridation of water have been raised over concerns that fluoride, in addition to preventing tooth decay, also can cause bone weakness if consumed in high doses over many years.

In 1986, the E.P.A. mandated that fluoride levels in water could not exceed 4.0 milligrams per liter. This regulation was accompanies by a suggestion that levels actually be limited to 2.0 milligrams per liter. Twenty years later, the National Research Council released a study it was asked by the E.P.A. to conduct. The study indicated that the 4.0 maximum level should be lowered, though it does not specify by how much. Today, the E.P.A. is still pondering how to proceed.

It seems that other federal agencies are beginning to take notice of the issue as well. In January 2011, the Department of Health and Human Services recommended that fluoride levels be capped at 0.7 milligrams per liter.

In light of these findings and recommendations, cities throughout the country have begun to explore the issue in greater detail. While many cities in New Jersey have elected to abandon fluoride in local water, others like Aspen, CO and Shippensburg, PA have elected to continue adding it.

If you or a loved one has been harmed by a toxic substance, click here to contact our firm for a complementary consultation. A member of our staff who specializes in toxic torts will be happy to speak with you.

To learn more about fluoride in water, please see any of the following sources:

Blog at WordPress.com.
The Esquire Theme.

Follow

Get every new post delivered to your Inbox.